NCT03978403 A Four-way Crossover Study of 3 Formulations of M207 With Intranasal Zolmitriptan in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03962738 A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine Status COMPLETED Phase PHASE2
NCT03934086 An Open-label, Intermediate Size, Expanded Access Study of BHV-3000 in the Acute Treatment of Migraine Status NO_LONGER_AVAILABLE Phase N/A
NCT03912337 Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine Status TERMINATED Phase PHASE4
NCT03902496 Optical Treatment of Migraines Using the Avulux™ Optical Filter in the Form of Spectacle Lenses. Status COMPLETED Phase NA
NCT03901482 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine Status COMPLETED Phase PHASE3
NCT03877718 A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain Status COMPLETED Phase PHASE2
NCT03874832 A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03872453 Acute Treatment Trial in Adult Subjects With Migraines Status COMPLETED Phase PHASE2/PHASE3
NCT03867201 Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients Status COMPLETED Phase PHASE3
NCT03847753 Exploring the Comorbidity Between Mental Disorders and General Medical Conditions Status COMPLETED Phase N/A
NCT03836664 A Randomized Study Evaluating the Efficacy and Safety of Timolol Ophthalmic Solution as an Acute Treatment of Migraine Status COMPLETED Phase PHASE2
NCT03836040 Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03832998 Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Status COMPLETED Phase PHASE3
NCT03828539 Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine Status COMPLETED Phase PHASE4